The Role of DNA/RNA Hybrids on the Efficiency of Nuclease-Free Genome Editing and AAV Integration In Vivo

被引：0
|
作者：
Puzzo, Francesco [1 ]
Crossley, Madzia P. [2 ]
Pekrun, Katja [1 ]
Goswami, Aranyak [1 ]
Zhang, Feijie [1 ]
Cimprich, Karlene [2 ]
Kay, Mark A. [1 ]
机构：
[1] Stanford Univ, Genet & Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Chem & Syst Biol, Stanford, CA 94305 USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1080
引用
收藏
页码：518 / 518
页数：1
相关论文
共 37 条
  • [1] Nuclease-Free Promoterless Genome Editing for Wilson Disease
    Padula, Agnese
    Spinelli, Michele
    Capolongo, Filomena
    Amoresano, Angela
    Piccolo, Pasquale
    MOLECULAR THERAPY, 2022, 30 (04) : 41 - 42
  • [2] In Vivo Precise Nuclease-Free Genome Editing of the Murine MeCP2 Gene
    Bijlani, Swati
    Pang, Ka Ming
    Rangasamy, Sampath
    Bugga, Lakshmi
    Narayanan, Vinodh
    Chatterjee, Saswati
    MOLECULAR THERAPY, 2024, 32 (04) : 752 - 753
  • [3] Exploiting the Regenerative Capacity of Liver for Nuclease-Free Genome Editing
    Puzzo, Francesco
    De Alencastro, Gustavo
    Patijn, Gijsbert Andries
    Zhang, Feijie
    Pekrun, Katja
    Kay, Mark
    MOLECULAR THERAPY, 2019, 27 (04) : 463 - 463
  • [4] Deciphering the Mechanism of Nuclease-Free Homologous Recombination Based Genome Editing
    Bugga, Lakshmi V.
    Sivanandam, Venkatesh
    Rodriguez, Esther
    Pang, Ka Ming
    Chatterjee, Saswati
    MOLECULAR THERAPY, 2023, 31 (04) : 762 - 762
  • [5] Demonstration of Nuclease-Free Genome Editing (GeneRide™) in Pediatric Patients with Methylmalonic Acidemia
    Payton, Marie
    Morgan, Thomas
    Bedoyan, Jirair K.
    Sun, Angela
    Li, Hong
    Gruskin, Daniel
    Kay, Mark A.
    Chereau, Frederic
    Vockley, Jerry
    MOLECULAR THERAPY, 2024, 32 (04) : 80 - 81
  • [6] CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
    Dasgupta, Ishani
    Flotte, Terence R.
    Keeler, Allison M.
    HUMAN GENE THERAPY, 2021, 32 (5-6) : 275 - 293
  • [7] AAVHSC Nuclease-Free Genome Editing Leads to In Vivo Genome Correction and a Significant Reduction in Disease Phenotype in a Mouse Model of Phenylketonuria
    Wright, Jason
    Smith, Laura
    Adamson-Small, Laura
    Ahmed, Seemin
    Avila, Nancy
    Burnham, Brenda
    Chatterjee, Saswati
    Dollive, Serena
    Ellsworth, Jeff
    Faulkner, Deiby
    Francone, Omar
    Kivaa, Monicah
    Knowlton, David
    Prout, Jaime
    Rubin, Hillard
    Scarpitti, Meghan
    Sengooba, Arnold
    St Martin, Thia
    Seymour, Albert
    MOLECULAR THERAPY, 2018, 26 (05) : 227 - 228
  • [8] Nuclease-free genome editing by AAVHSC vectors leads to in vivo genome correction and amelioration of disease phenotype in a mouse model of phenylketonuria (PKU)
    Ellsworth, J.
    StMartin, T.
    Avila, N.
    Benard, L.
    Chen, H. M.
    Chittoda, M.
    Dollive, S.
    Lamppu, D.
    Lotterhand, J.
    Lobikin, M.
    Resendes, R.
    Rubin, H.
    Scarpitti, M.
    Sengooba, A.
    Adamson-Small, L.
    Sookiasian, D.
    Zhang, Y.
    Francone, O.
    Seymour, A.
    Wright, J.
    HUMAN GENE THERAPY, 2019, 30 (11) : A16 - A16
  • [9] Nuclease-Free Gene Editing with Peptide Nucleic Acids: A New Class of In Vivo Gene Editors
    Stoltzfus, Dani M.
    Riedl, William
    Chen, Lyuqin
    Spiker, Lindsey R.
    Murphy, Steven M.
    Tavenor, Nathan
    Badeau, Barry
    Gleaton, Jeremy W.
    Stephan, Dietrich A.
    MOLECULAR THERAPY, 2023, 31 (04) : 181 - 182
  • [10] DNA/RNA hybrids as double edge sword: r-loops can influence the efficiency of AAV-mediated genome editing and undesired vector integrations in vivo
    Puzzo, F.
    Crossley, M. P.
    Goswami, A.
    Pekrun, K.
    Zhang, F.
    Cimprich, K.
    Kay, M. A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A9 - A9
1234